MORTIMER IAN
PRESIDENT & CEO · 11 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-13 | XENE | Xenon Pharmaceuticals Inc. | Sale | 7,308 | $55.23 | $403,584.30 | filing |
| 2026-03-12 | XENE | Xenon Pharmaceuticals Inc. | Option exercise | 12,500 | — | — | filing |
| 2026-01-02 | XENE | Xenon Pharmaceuticals Inc. | Sale | 37,938 | $44.40 | $1.7M | filing |
| 2026-01-02 | XENE | Xenon Pharmaceuticals Inc. | Option exercise | 40,000 | $7.49 | $299,600.00 | filing |
| 2026-01-02 | XENE | Xenon Pharmaceuticals Inc. | Sale | 2,062 | $44.93 | $92,645.66 | filing |
| 2025-12-08 | XENE | Xenon Pharmaceuticals Inc. | Sale | 8,820 | $45.59 | $402,103.80 | filing |
| 2025-12-08 | XENE | Xenon Pharmaceuticals Inc. | Sale | 2,010 | $46.32 | $93,103.20 | filing |
| 2025-12-05 | XENE | Xenon Pharmaceuticals Inc. | Sale | 14,375 | $45.03 | $647,306.25 | filing |
| 2025-11-28 | XENE | Xenon Pharmaceuticals Inc. | Sale | 97 | $45.01 | $4,365.97 | filing |
| 2025-10-01 | XENE | Xenon Pharmaceuticals Inc. | Sale | 25,000 | $40.16 | $1.0M | filing |
| 2025-10-01 | XENE | Xenon Pharmaceuticals Inc. | Option exercise | 25,000 | $7.69 | $192,250.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.